Yoshizawa Hidenori, Itani Hikaru, Ishikura Koji, Irie Tadashi, Yokoo Katsuki, Kubota Tadatoshi, Minami Kyoji, Iwaki Tsutomu, Miwa Hideaki, Nishitani Yasuhiro
Shionogi Research Laboratories, Shionogi & Co., Ltd., Fukushima-ku, Osaka 553, Japan.
J Antibiot (Tokyo). 2002 Nov;55(11):975-92. doi: 10.7164/antibiotics.55.975.
A series of 7-aminothiadiazolylcephalosporins having a 1-(substituted)-1H-imidazo[4,5-b]pyridinium group at the C-3' position of the cephem nucleus were synthesized and evaluated for in vitro antibacterial activities. Among the cephalosporins prepared in this study, 7beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)-ethoxyiminoacetamido]-3-[1-(3-methylaminopropyl)-1H-imidazo[4,5-b]pyridinium-4-yl]methyl-3-cephem-4-carboxylate sulfate (S-3578) showed extremely potent broad spectrum activity against both gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA) and gram-negative bacteria including Pseudomonas aeruginosa, and good water solubility.
合成了一系列在头孢烯核的C-3'位具有1-(取代)-1H-咪唑并[4,5-b]吡啶鎓基团的7-氨基噻二唑基头孢菌素,并对其体外抗菌活性进行了评估。在本研究制备的头孢菌素中,7β-[2-(5-氨基-1,2,4-噻二唑-3-基)-2(Z)-乙氧基亚氨基乙酰胺基]-3-[1-(3-甲基氨基丙基)-1H-咪唑并[4,5-b]吡啶-4-基]甲基-3-头孢烯-4-羧酸酯硫酸盐(S-3578)对包括耐甲氧西林金黄色葡萄球菌(MRSA)在内的革兰氏阳性菌和包括铜绿假单胞菌在内的革兰氏阴性菌均显示出极强的广谱活性,且具有良好的水溶性。